Evidence map›Paper›PMID 38927448›Full record

ArticleBiomedicines2024

Prospects for Prostate Cancer Chemotherapy: Cytotoxic Evaluation and Mechanistic Insights of Quinolinequinones with ADME/PK Profile.

Ayse Tarbin Jannuzzi, Ayse Mine Yilmaz Goler, Abanish Biswas, Subodh Mondal, Vinay N Basavanakatti, Hatice Yıldırım, Mahmut Yıldız, Nilüfer Bayrak, Venkatesan Jayaprakash, Amaç Fatih TuYuN

Abstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ayse Tarbin JannuzziDepartment of Pharmaceutical Toxicology, Faculty of Pharmacy, İstanbul University, 34116 İstanbul, Türkiye.ORCID 0000-0003-0578-6893
Ayse Mine Yilmaz GolerDepartment of Biochemistry, School of Medicine/Genetic and Metabolic Diseases Research and Investigation Center, Marmara University, 34854 İstanbul, Türkiye.ORCID 0000-0003-0802-523X
Abanish BiswasDepartment of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India.ORCID 0000-0002-4871-0453
Subodh MondalBioanalysis, Eurofins Advinus BioPharma Services India Pvt Ltd., Bengaluru 560058, Karnataka, India.
Vinay N BasavanakattiAdgyl Lifesciences Private Limited, Bengaluru 560058, Karnataka, India.
Hatice YıldırımDepartment of Chemistry, Engineering Faculty, Istanbul University-Cerrahpasa, Avcılar, 34320 İstanbul, Türkiye.ORCID 0000-0003-3988-6120
Mahmut YıldızDepartment of Chemistry, Gebze Technical University, Gebze, 41400 Kocaeli, Türkiye.
Nilüfer BayrakDepartment of Chemistry, Faculty of Science, Istanbul University, Fatih, 34134 İstanbul, Türkiye.ORCID 0000-0002-0777-4012
Venkatesan JayaprakashDepartment of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India.ORCID 0000-0002-9724-4153
Amaç Fatih TuYuNDepartment of Chemistry, Faculty of Science, Istanbul University, Fatih, 34134 İstanbul, Türkiye.ORCID 0000-0001-5698-1109

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evaluation of in vitro biological activity of several previously reported quinolinequinones (

Indexed as

ADMEcytotoxicitymolecular dynamicsprostate cancerreactive oxygen species

Identifiers

PMID38927448
PMCPMC11200585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.